Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Jim Van Meerten

REVEALED: This red hot biopharma stock could fizzle out soon | Vintage Vibes

  • Roivant Sciences (ROIV) shows strong technical momentum and is trading at new all-time highs.
  • Shares are up 52% over the past year and 20% in the last month.
  • ROIV has a 100% “Buy” opinion from Barchart and a Trend Seeker “Buy” signal.
  • Despite the price gains, Roivant lacks consistent revenue and earnings growth. 

Today’s Featured Stock

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.